Skip to main content
Erschienen in: Esophagus 1/2017

28.06.2016 | Original Article

“Larynx-preserving surgery” for cervical esophageal carcinoma can preserve the vocal function and improve the clinical outcome

Erschienen in: Esophagus | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background/aim

At our institution, larynx-preserving surgery has been aggressively performed for cervical esophageal carcinoma, even when the oral side of the tumor margin extends beyond the esophageal orifice. Our aim was to clarify the clinical outcomes of surgery, with a focus on larynx-preserving surgery.

Patients and methods

Eleven patients who were diagnosed with resectable cervical esophageal carcinoma and received larynx-preserving surgery as the initial treatment were enrolled. For larynx-preserving surgery, the following two surgical techniques were introduced: the “larynx rotation method,” where the larynx and hypopharynx are manually rotated counterclockwise more than 90° by holding down the thyroid cartilage, and the “tracheal traction method,” where the trachea is moved forward with the larynx and hypopharynx. By selecting these methods, the transection of the cervical esophagus on the oral side of the tumor and anastomosis with a substituted organ can thus be achieved, even around the narrow area surrounded by the larynx, trachea and vertebral body. Nine patients who received definitive chemoradiotherapy as the initial treatment were also enrolled to compare the long-term clinical outcomes.

Results

Larynx-preserving surgery was successfully performed and the larynx could thus be preserved in all the cases. Although all patients developed recurrent nerve paralysis, including two patients who showed bilateral recurrent nerve paralysis, such paralysis was temporary. Although postoperative pneumonia, surgical site infection, and anastomotic stenosis were experienced, these problems were not severe and the postoperative morbidities were tolerable. The recurrence rate was 36.4 %, and the 5-year progression-free survival rate and overall survival rate were 62.3 and 90.9 %, respectively. There was no significant difference in the long-term clinical outcomes between the patients who underwent larynx-preserving surgery and chemoradiotherapy

Conclusions

Larynx-preserving surgery is considered to be acceptable because both organ preservation and functional preservation can be achieved with tolerable long-term clinical outcomes.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Zurück zum Zitat Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2008. Esophagus. 2015;12:130–57.CrossRef Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive registry of esophageal cancer in Japan, 2008. Esophagus. 2015;12:130–57.CrossRef
3.
Zurück zum Zitat Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.CrossRefPubMed Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.CrossRefPubMed
4.
Zurück zum Zitat Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefPubMed Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefPubMed
5.
Zurück zum Zitat Chou SH, Li HP, Lee JY, et al. Radical resection or chemoradiotherapy for cervical esophageal cancer? World J Surg. 2010;34:1832–9.CrossRefPubMed Chou SH, Li HP, Lee JY, et al. Radical resection or chemoradiotherapy for cervical esophageal cancer? World J Surg. 2010;34:1832–9.CrossRefPubMed
6.
Zurück zum Zitat Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed
7.
Zurück zum Zitat Nakajima Y, Kawada K, Tokairin Y, et al. Larynx-preserving surgery for cervical esophageal carcinoma. J Jpn Bronchoesophagol Soc. 2014;65:447–56 (Article in Japanese, abstract in English).CrossRef Nakajima Y, Kawada K, Tokairin Y, et al. Larynx-preserving surgery for cervical esophageal carcinoma. J Jpn Bronchoesophagol Soc. 2014;65:447–56 (Article in Japanese, abstract in English).CrossRef
8.
Zurück zum Zitat Tateya I, Morita S, Muto M, et al. Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope. 2015;125:1124–9.CrossRefPubMed Tateya I, Morita S, Muto M, et al. Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope. 2015;125:1124–9.CrossRefPubMed
9.
Zurück zum Zitat Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus. 2009;6:1–25.CrossRef
10.
Zurück zum Zitat Shiozaki H, Tsujinaka T, Inoue M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer–combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.CrossRefPubMed Shiozaki H, Tsujinaka T, Inoue M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer–combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.CrossRefPubMed
11.
Zurück zum Zitat Kadota H, Sakuraba M, Kimata Y, et al. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.CrossRefPubMed Kadota H, Sakuraba M, Kimata Y, et al. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.CrossRefPubMed
12.
Zurück zum Zitat Tong DK, Law S, Kwong DL, et al. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.CrossRefPubMed Tong DK, Law S, Kwong DL, et al. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.CrossRefPubMed
13.
Zurück zum Zitat Kamiyama R, Mitani H, Yonekawa H, et al. A clinical study of pharyngolaryngectomy with total esophagectomy: postoperative complications, countermeasures, and prognoses. Otolaryngol Head Neck Surg. 2015;153:392–9.CrossRefPubMed Kamiyama R, Mitani H, Yonekawa H, et al. A clinical study of pharyngolaryngectomy with total esophagectomy: postoperative complications, countermeasures, and prognoses. Otolaryngol Head Neck Surg. 2015;153:392–9.CrossRefPubMed
14.
Zurück zum Zitat Peracchia A, Bonavina L, Botturi M, et al. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus. 2001;14:95–7.CrossRefPubMed Peracchia A, Bonavina L, Botturi M, et al. Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus. 2001;14:95–7.CrossRefPubMed
15.
Zurück zum Zitat Daiko H, Hayashi R, Sakuraba M, et al. A pilot study of post-operative radiotherapy with concurrent chemotherapy for high-risk squamous cell carcinoma of the cervical esophagus. Jpn J Clin Oncol. 2011;41:508–13.CrossRefPubMed Daiko H, Hayashi R, Sakuraba M, et al. A pilot study of post-operative radiotherapy with concurrent chemotherapy for high-risk squamous cell carcinoma of the cervical esophagus. Jpn J Clin Oncol. 2011;41:508–13.CrossRefPubMed
16.
Zurück zum Zitat Cao CN, Liu SY, Luo JW, et al. Pattern of failure in surgically treated patients with cervical esophageal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2014;151:260–4.CrossRefPubMed Cao CN, Liu SY, Luo JW, et al. Pattern of failure in surgically treated patients with cervical esophageal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2014;151:260–4.CrossRefPubMed
Metadaten
Titel
“Larynx-preserving surgery” for cervical esophageal carcinoma can preserve the vocal function and improve the clinical outcome
Publikationsdatum
28.06.2016
Erschienen in
Esophagus / Ausgabe 1/2017
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-016-0547-3

Weitere Artikel der Ausgabe 1/2017

Esophagus 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.